Outcomes of xerostomia-related quality of life for nasopharyngeal carcinoma treated by IMRT: based on the EORTC QLQ-C30 and H&N35 questionnaires

References

• Lo KW, To KF, Huang DP. Focus on nasopharyngeal carcinoma. Cancer Cell 2004;5(5):423-8
   PubMed Web of Science ®Google Scholar
• Cengiz M, Ozyar E, Esassolak M, et al. Assessment of quality of life of nasopharyngeal carcinoma patients with EORTC QLQ-C30 and H&N-35 modules. Int J Radiat Oncol Biol Phys 2005;63(5):1347-53
   PubMed Web of Science ®Google Scholar
• Chao KS, Ozyigit G, Blanco AI, et al. Intensity-modulated radiation therapy for oropharyngeal carcinoma: impact of tumor volume. Int J Radiat Oncol Biol Phys 2004;59(1):43-50
   PubMed Web of Science ®Google Scholar
• Lee AW, Lin JC, Ng WT. Current management of nasopharyngeal cancer. Semin Radiat Oncol 2012;22(3):233-44
   PubMed Web of Science ®Google Scholar
• List MA, Stracks J. Evaluation of quality of life in patients definitively treated for squamous carcinoma of the head and neck. Curr Opin Oncol 2000;12(3):215-20
   PubMed Web of Science ®Google Scholar
• Terrell JE, Nanavati K, Esclamado RM, et al. Health impact of head and neck cancer. Otolaryngol Head Neck Surg 1999;120(6):852-9
   PubMed Web of Science ®Google Scholar
• Jensen SB, Pedersen AM, Vissink A, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer 2010;18(8):1061-79
   PubMed Web of Science ®Google Scholar
• Kam MK, Leung SF, Zee B, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007;25(31):4873-9
   PubMed Web of Science ®Google Scholar
• Pow EH, Kwong DL, McMillan AS, et al. Xerostomia and quality of life after intensity-modulated radiotherapy vs. conventional radiotherapy for early-stage nasopharyngeal carcinoma: initial report on a randomized controlled clinical trial. Int J Radiat Oncol Biol Phys 2006;66(4):981-91
   PubMed Web of Science ®Google Scholar
• Fang FM, Chien CY, Tsai WL, et al. Quality of life and survival outcome for patients with nasopharyngeal carcinoma receiving three-dimensional conformal radiotherapy vs. intensity-modulated radiotherapy-a longitudinal study. Int J Radiat Oncol Biol Phys 2008;72(2):356-64
   PubMed Web of Science ®Google Scholar
• Jensen SB, Pedersen AM, Vissink A, et al. A systematic review of salivary gland hypofunction and xerostomia induced by cancer therapies: management strategies and economic impact. Support Care Cancer 2010;18(8):1061-79
   PubMed Web of Science ®Google Scholar
• McMillan AS, Pow EH, Kwong DL, et al. Preservation of quality of life after intensity-modulated radiotherapy for early-stage nasopharyngeal carcinoma: results of a prospective longitudinal study. Head Neck 2006;28(8):712-22
   PubMed Web of Science ®Google Scholar
• Pow EH, Kwong DL, Sham JS, et al. Can intensity-modulated radiotherapy preserve oral health-related quality of life of nasopharyngeal carcinoma patients? Int J Radiat Oncol Biol Phys 2012;83(2):e213-21
   PubMed Web of Science ®Google Scholar
• Fang FM, Tsai WL, Chen HC, et al. Intensity-modulated or conformal radiotherapy improves the quality of life of patients with nasopharyngeal carcinoma: comparisons of four radiotherapy techniques. Cancer 2007;109(2):313-21
   PubMed Web of Science ®Google Scholar
• Fang FM, Tsai WL, Lee TF, et al. Multivariate analysis of quality of life outcome for nasopharyngeal carcinoma patients after treatment. Radiother Oncol 2010;97(2):263-9
   PubMed Web of Science ®Google Scholar
• Tsai WL, Chien CY, Huang HY, et al. Prognostic value of quality of life measured after treatment on subsequent survival in patients with nasopharyngeal carcinoma. Qual Life Res 2013;22(4):715-23
   PubMed Web of Science ®Google Scholar
• Liu YJ, Zhu GP, Guan XY. Comparison of the NCI-CTCAE version 4.0 and version 3.0 in assessing chemoradiation-induced oral mucositis for locally advanced nasopharyngeal carcinoma. Oral Oncol 2012;48(6):554-9
   PubMed Web of Science ®Google Scholar
• Meng Z, Kay Garcia M, Hu C, et al. Sham-controlled, randomised, feasibility trial of acupuncture for prevention of radiation-induced xerostomia among patients with nasopharyngeal carcinoma. Eur J Cancer 2012;48(11):1692-9
   PubMed Web of Science ®Google Scholar
• Fang FM, Tsai WL, Chien CY, et al. Pretreatment quality of life as a predictor of distant metastasis and survival for patients with nasopharyngeal carcinoma. J Clin Oncol 2010;28(28):4384-9
   PubMed Web of Science ®Google Scholar
• Yang H, Hu W, Wang W, et al. Replanning during intensity modulated radiation therapy improved quality of life in patients with nasopharyngeal carcinoma. Int J Radiat Oncol Biol Phys 2013;85(1):e47-54
   PubMed Web of Science ®Google Scholar
• Ma L, Guo Q, Zhang Y, et al. The effect of intensity-modulated radiotherapy versus conventional radiotherapy on quality of life in patients with nasopharyngeal cancer: a cross-sectional study. Head Neck Oncol 2013;5(1):8
   Google Scholar
• Vergeer MR, Doornaert PA, Rietveld DH, et al. Intensity-modulated radiotherapy reduces radiation-induced morbidity and improves health-related quality of life: results of a nonrandomized prospective study using a standardized follow-up program. Int J Radiat Oncol Biol Phys 2009;74(1):1-8
   PubMed Web of Science ®Google Scholar
• Chen AM, Farwell DG, Luu Q, et al. Intensity-modulated radiotherapy is associated with improved global quality of life among long-term survivors of head-and-neck cancer. Int J Radiat Oncol Biol Phys 2012;84(1):170-5
   PubMed Web of Science ®Google Scholar
• Wan Leung S, Lee TF, Chien CY, et al. Health-related quality of life in 640 head and neck cancer survivors after radiotherapy using EORTC QLQ-C30 and QLQ-H&N35 questionnaires. BMC Cancer 2011;11:128
   PubMed Web of Science ®Google Scholar
• van Rij CM, Oughlane-Heemsbergen WD, Ackerstaff AH, et al. Parotid gland sparing IMRT for head and neck cancer improves xerostomia related quality of life. Radiat Oncol 2008;3:41
   PubMed Web of Science ®Google Scholar
• Graff P, Lapeyre M, Desandes E, et al. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy. Int J Radiat Oncol Biol Phys 2007;67(5):1309-17
   PubMed Web of Science ®Google Scholar
• Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 1993;85(5):365-76
   PubMed Web of Science ®Google Scholar
• Fayers P, Bottomley A; Group EQoL, Quality of Life U. Quality of life research within the EORTC-the EORTC QLQ-C30. European Organisation for Research and Treatment of Cancer. Eur J Cancer 2002;38(Suppl 4):S125-33
   PubMed Web of Science ®Google Scholar
• Bjordal K, Hammerlid E, Ahlner-Elmqvist M, et al. Quality of life in head and neck cancer patients: validation of the European Organization for Research and Treatment of Cancer Quality of Life Questionnaire-H&N35. J Clin Oncol 1999;17(3):1008-19
   PubMed Web of Science ®Google Scholar
• Lu H, Yao M. The current status of intensity-modulated radiation therapy in the treatment of nasopharyngeal carcinoma. Cancer Treat Rev 2008;34(1):27-36
   PubMed Web of Science ®Google Scholar
• Amit M, Abergel A, Fliss DM, Gil Z. The clinical importance of quality-of-life scores in patients with skull base tumors: a meta-analysis and review of the literature. Curr Oncol Rep 2012;14(2):175-81
   PubMed Web of Science ®Google Scholar
• Hess CB, Chen AM. Global and health-related quality of life after intensity-modulated radiation therapy for head and neck cancer. Expert Rev Anticancer Ther 2012;12(11):1469-77
   PubMed Web of Science ®Google Scholar
• Xie CY, Su HF, Li WF, et al. [The effect on life quality of nasopharyngeal cancer patients through xerostomia decrease after intensity-modulated radiotherapy]. Zhonghua Yi Xue Za Zhi 2010;90(19):1313-16
   PubMedGoogle Scholar
• Nutting CM, Morden JP, Harrington KJ, et al. Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial. Lancet Oncol 2011;12(2):127-36
   PubMed Web of Science ®Google Scholar
• Chang YC, Chen SY, Lui LT, et al. Dysphagia in patients with nasopharyngeal cancer after radiation therapy: a videofluoroscopic swallowing study. Dysphagia 2003;18(2):135-43
   PubMed Web of Science ®Google Scholar
• Hughes PJ, Scott PM, Kew J, et al. Dysphagia in treated nasopharyngeal cancer. Head Neck 2000;22(4):393-7
   PubMed Web of Science ®Google Scholar
• Peng G, Wang T, Yang KY, et al. A prospective, randomized study comparing outcomes and toxicities of intensity-modulated radiotherapy vs. conventional two-dimensional radiotherapy for the treatment of nasopharyngeal carcinoma. Radiother Oncol 2012;104(3):286-93
   PubMed Web of Science ®Google Scholar
• Lin A, Kim HM, Terrell JE, et al. Quality of life after parotid-sparing IMRT for head-and-neck cancer: a prospective longitudinal study. Int J Radiat Oncol Biol Phys 2003;57(1):61-70
   PubMed Web of Science ®Google Scholar
• Hsiung CY, Ting HM, Huang HY, et al. Parotid-sparing intensity-modulated radiotherapy (IMRT) for nasopharyngeal carcinoma: preserved parotid function after IMRT on quantitative salivary scintigraphy, and comparison with historical data after conventional radiotherapy. Int J Radiat Oncol Biol Phys 2006;66(2):454-61
   PubMed Web of Science ®Google Scholar
• Yeh SA, Tang Y, Lui CC, et al. Treatment outcomes and late complications of 849 patients with nasopharyngeal carcinoma treated with radiotherapy alone. Int J Radiat Oncol Biol Phys 2005;62(3):672-9
   PubMed Web of Science ®Google Scholar
• Hunt MA, Zelefsky MJ, Wolden S, et al. Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancer. Int J Radiat Oncol Biol Phys 2001;49(3):623-32
   PubMed Web of Science ®Google Scholar
• Nowak PJ, Wijers OB, Lagerwaard FJ, Levendag PC. A three-dimensional CT-based target definition for elective irradiation of the neck. Int J Radiat Oncol Biol Phys 1999;45(1):33-9
   PubMed Web of Science ®Google Scholar
• Wu VW, Ying MT, Kwong DL. Evaluation of radiation-induced changes to parotid glands following conventional radiotherapy in patients with nasopharygneal carcinoma. Br J Radiol 2011;84(1005):843-9
   PubMed Web of Science ®Google Scholar
• Fiorentino A, Caivano R, Metallo V, et al. Parotid gland volumetric changes during intensity-modulated radiotherapy in head and neck cancer. Br J Radiol 2012;85(1018):1415-19
   PubMed Web of Science ®Google Scholar
• Fiorentino A, Cozzolino M, Caivano R, et al. Cone-beam computed tomography dose monitoring during intensity-modulated radiotherapy in head and neck cancer: parotid glands. Clin Trans Oncol 2013;15(5):412-15
   PubMed Web of Science ®Google Scholar
• Fiorentino A, Cozzolino M, Caivano R, et al. Head and neck intensity modulated radiotherapy parotid glands: time of re-planning. Radiol Med (Torino) 2014;119(3):201-7
   PubMed Web of Science ®Google Scholar